Key Insights

Highlights

Success Rate

84% trial completion

Published Results

19 trials with published results (13%)

Research Maturity

77 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.6%

15 terminated out of 142 trials

Success Rate

83.7%

-2.8% vs benchmark

Late-Stage Pipeline

13%

19 trials in Phase 3/4

Results Transparency

25%

19 of 77 completed with results

Key Signals

19 with results84% success15 terminated

Data Visualizations

Phase Distribution

99Total
Not Applicable (33)
Early P 1 (3)
P 1 (22)
P 2 (22)
P 3 (16)
P 4 (3)

Trial Status

Completed77
Recruiting20
Unknown19
Terminated15
Not Yet Recruiting5
Withdrawn4

Trial Success Rate

83.7%

Benchmark: 86.5%

Based on 77 completed trials

Clinical Trials (142)

Showing 20 of 20 trials
NCT06989437Phase 2RecruitingPrimary

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

NCT07288619Not ApplicableCompleted

Therapeutic Efficacy of Nutritional Supplementation in Cachexia Associated With Chronic Pulmonary Disease

NCT05546476Phase 2Completed

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

NCT06736275Early Phase 1Recruiting

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

NCT07083557Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

NCT07565415Phase 2Not Yet Recruiting

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

NCT07338487Phase 1Recruiting

A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

NCT03606317Active Not RecruitingPrimary

Retrospective Review of Cachexia in Lung and Gastrointestinal Cancer Patients

NCT07530666Phase 1Not Yet Recruiting

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

NCT06077734Terminated

Muscle Stem Cell Quality in Atrophy

NCT05376592Recruiting

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

NCT07356037Phase 3Not Yet RecruitingPrimary

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

NCT03191955CompletedPrimary

Muscle Wasting in Cancer (MWIC)

NCT05865535Phase 1RecruitingPrimary

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

NCT05642819RecruitingPrimary

REVOLUTION Surgery (REVOLUTION Surgery)

NCT02330926Phase 3CompletedPrimary

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

NCT07130981Recruiting

Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients

NCT05899205RecruitingPrimary

Patient Recorded Indexing Measurements

NCT07112482Not ApplicableCompleted

Effect of Dietary Counseling and Nutritional Monitoring in Reducing Cancer-related Cachexia Among Female Oncology Patients

NCT07107087Not ApplicableNot Yet RecruitingPrimary

A Cluster Randomised Controlled Trial of a Multimodal Integrated Intervention for Kidney Cachexia

Scroll to load more

Research Network

Activity Timeline